The Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences provides national and international recognition and support to those at the forefront of cardiovascular sciences.

The recipient will be a leader in cardiovascular sciences, a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care.

The Schottenstein Laureate will also receive an honorarium of $100,000 (US).

Established by a $2 million endowment from humanitarian philanthropists Jay and Jeanie Schottenstein, the prize is chartered to The Ohio State University Wexner Medical Center’s Heart and Vascular Center, and will be awarded biennially.

2023 Schottenstein Prize Laureate


Richard Kitsis, MD

Richard Kitsis, MD, is a professor of Medicine and Cell Biology, where he holds the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease. He also serves as the Director of the Wilf Family Cardiovascular Research Institute at the Albert Einstein College of Medicine and Montefiore Medicine in New York City. His laboratory has delineated fundamental mechanisms of cell death and roles of cell death in heart disease. This work has established that regulated forms of cell death are primarily responsible for heart damage during myocardial infarction and delineated novel molecular mechanisms that have provided the basis for drug development.

Past Winners of the Schottenstein Prize


Dan Roden, MD

2019 Laureate

Dan Roden, MD, is at Vanderbilt University School of Medicine, where he serves as a professor of Medicine, Pharmacology and Biomedical Informatics and senior vice president for Personalized Medicine at Vanderbilt University Medical Center. After serving as chief of the Division of Clinical Pharmacology for 12 years, he was tasked in 2006 with leading Vanderbilt’s efforts in personalized medicine. He’s been principal investigator for the Vanderbilt sites of the Pharmacogenomics Research Network since 2001 and of the Electronic Medical Records and Genomics Network since 2007.

Helen Hobbs

Helen Hobbs, MD

2017 Prize Laureate

Helen Hobbs, MD, is a professor of Internal Medicine and Molecular Genetics at UT Southwestern Medical Center. She is co-director of the Hobbs-Cohen Lab in the Eugene McDermott Center for Human Growth and Development. Since 2002, she has been a Howard Hughes Investigator. Dr. Hobbs was elected to the Institute of Medicine in 2004 and the National Academy of Sciences in 2007, and was awarded the Breakthrough Prize in Life Sciences in 2015 and the Passano Award (with Jonathan Cohen) in 2016. She is the Philip O'Bryan Montgomery Jr., M.D., Distinguished Chair in Developmental Biology and the Eugene McDermott Distinguished Chair for the Study of Human Growth and Development.


Roberto Bolli, MD, FAHA

2015 Prize Laureate

Roberto Bolli,MD, is professor of Medicine, Physiology and Biophysics; Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology; executive vice chair of the Department of Medicine; director of the Institute of Molecular Cardiology; and Distinguished University Scholar at the University of Louisville School of Medicine.


Garret FitzGerald, MD

2013 Prize Laureate

Garret FitzGerald, MD, is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics.


Christine Seidman, MD

2011 Prize Laureate

Christine Seidman, MD, is professor in the departments of Medicine and Genetics at Harvard Medical School and Brigham and Women’s Hospital, where she is also the Thomas W. Smith Professor of Medicine.


Pascal Goldschmidt, MD

2009 Prize Laureate

Pascal Goldschmidt, MD, was the inaugural recipient of the Schottenstein Prize. He’ is a cardiologist and cardiovascular researcher, and former dean of the University of Miami Leonard M. Miller School of Medicine. Until January 2016, he also served as chief executive officer of the University of Miami Health System. He is currently president and CEO of American Healthcare System, European Care Global and Alzady International.

Schottenstein Prize in Cardiovascular Sciences


Eligibility and Award Details

This prestigious prize provides national and international recognition to a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care.

Those honored will be practitioners and/or scientists whose accomplishments and contributions have taken place over a career of dedicated and focused scientific discovery.

The prize is awarded biennially.

Jay and Jeanie Schottensteins

About Jay and Jeanie Schottenstein

In 2008, Jay and Jeanie Schottenstein endowed $2 million to The Ohio State University Wexner Medical Center to create the Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences. As Ohio natives, Jay and Jeanie provided the prize to further establish Ohio State as a leader in cardiovascular care at a global level.

With an extensive record of charitable giving to local, national and international causes, the Schottensteins ensure decades of cardiovascular excellence at Ohio State with this prize that honors those who have made extraordinary contributions to improving the field of heart and vascular research and patient care.

Read more